Headache News and Research

Latest Headache News and Research

Infusion treatments for low iron can deplete patients’ wallets

Shannon Wood Rothenberg walked into her annual physical feeling fine. But more than a year later, she's still paying the price.

2 Aug 2019

FDA clears existing tests with new indications to aid in the diagnosis of Lyme disease

Today, the U.S. Food and Drug Administration cleared for marketing four previously cleared tests with new indications to aid in the diagnosis of Lyme disease.

30 Jul 2019

Sequencing data could be used to prevent lyme disease

Researchers have successfully sequenced the genome of the animal that could carry the bacteria causing Lyme disease.

25 Jul 2019

FDA approves first nasal glucagon therapy for treatment of severe hypoglycemia

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that can be administered without an injection.

24 Jul 2019

Tips to stay cool and healthy in the heat

Hot weather is here. That means it's the perfect time to go for a swim or relax in the shade. But before lathering on the sunscreen and heading outdoors, it's important to know the signs of heat-related injuries and how to stay cool when the temperatures soar.

19 Jul 2019

Defective potassium channels linked only with headaches, not body pain

Defective potassium channels involved in pain detection can increase the chance of developing a headache and could be implicated in migraines, according to research in mice published in eNeuro.

From Society for Neuroscience 19 Jul 2019

Johns Hopkins designs criteria for diagnostic imaging tests

On June 30, the Centers for Medicare & Medicaid Services (CMS) announced that the Johns Hopkins University School of Medicine has been designated a so-called “qualified provider-led entity.”

From Johns Hopkins Medicine 19 Jul 2019

WHO declares the deadly Ebola outbreak in Congo a global health emergency

Ebola, the deadly viral infection, is spreading in Congo and the World Health Organization (WHO) has announced it as an international health emergency. Speaking in front of reporters, WHO Director-General Tedros Adhanom Ghebreyesus gave updates on the situation in the Central African country.

18 Jul 2019

FDA approves antibacterial drug to treat complicated urinary tract infections, intra-abdominal infections

The U.S. Food and Drug Administration has approved Recarbrio (imipenem, cilastatin and relebactam), an antibacterial drug product to treat adults with complicated urinary tract infections (cUTI) and complicated intra-abdominal infections (cIAI).

17 Jul 2019

Stroke should be treated 15 minutes earlier to save lives, study suggests

A team of researchers at the David Geffen School of Medicine in the University of California, Los Angeles (UCLA) wanted to determine the association between time to treatment with Endovascular Reperfusion Therapy and outcomes in patients with acute ischemic stroke.

17 Jul 2019

Mosquito surveillance in Madagascar reveals new insight into malaria transmission

The Ministry of Public Health in Madagascar has reported thousands of malaria cases over the past months. In March, more than 600 cases of malaria were reported weekly and at least 2,000 cases have been reported in less than a month. As a result, efforts to curb the outbreak were initiated.

12 Jul 2019

New drug for acute migraine shows promising results in a large-scale trial

A drug belonging to a new generation of acute migraine headache treatments was found to eliminate pain and reduce bothersome symptoms for people with migraine in a large-scale trial reported in the July 11 issue of The New England Journal of Medicine.

11 Jul 2019

Use of statins linked to reduction of mortality risk in dementia patients

The use of statins is significantly associated with a reduction in the risk of mortality in dementia patients, new research presented today at the 5th European Academy of Neurology Congress has shown.

1 Jul 2019

New strategies for preventing and coping with rising burden of brain diseases

New strategies for preventing and coping with the growing burden of brain diseases were outlined today at the 5th European Academy of Neurology Congress in Oslo, Norway.

1 Jul 2019

Multiple Sclerosis patients may have greater risk of developing cancer

New results of a 65-year follow-up study of nearly 7,000 Norwegian patients with Multiple Sclerosis suggest that patients may have a greater overall risk of developing cancer than the general population, with an especially high risk of cancer in respiratory organs, urinary organs and the central nervous system.

1 Jul 2019

New technology helps clinicians 'see' and map patient's pain in real-time

Many patients, especially those who are anesthetized or emotionally challenged, cannot communicate precisely about their pain.

28 Jun 2019

Research project to investigate causes of persistent anemia among Peruvian children

The causes of persistent high levels of anemia among Peruvian children will be investigated by a new study led by Queen Mary University of London and the Instituto Nacional de Salud del Niño, in collaboration with Universidad Nacional Intercultural de la Amazonia and Universidad Nacional San Christobal de Huamanga in Peru.

27 Jun 2019

Pregnant women with migraine more often have complications during pregnancy and childbirth

Despite the fact that many women who suffer migraines find that the number and severity of these severe headaches decrease during pregnancy, migraines are now being linked to elevated blood pressure, abortions, caesareans, preterm births and babies with low birth weight.

26 Jun 2019

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

23 Jun 2019

FDA expands approval of cystic fibrosis treatment to include pediatric patients as young as 6 years old

The U.S. Food and Drug Administration today expanded the indication for Symdeko (a combination of tezacaftor/ivacaftor) tablets for treatment of pediatric patients ages 6 years and older with cystic fibrosis who have certain genetic mutations.

22 Jun 2019